Is KURA or MGTX more profitable?

MGTX runs the higher net margin — KURA at -384.30% versus MGTX at 19.87%.

How have KURA and MGTX total returns compared?

Over the past 5 years, KURA delivered -10.73% and MGTX delivered -3.10% annualized total return. Past performance doesn't predict future results.

Kura Oncology, Inc. (KURA) vs MeiraGTx Holdings plc (MGTX)

A side-by-side comparison of Kura Oncology, Inc. and MeiraGTx Holdings plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KURA

Kura Oncology, Inc.

$936M

$10.54HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

MGTX

MeiraGTx Holdings plc

$989M

$10.68HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — KURA vs MGTX

growth of $100 · dividends reinvested · last 8y

KURA -38.8% (-6.0%/yr)MGTX -27.2% (-3.9%/yr)MGTX compounded faster over this window

KURA MGTX

KURA vs MGTX: by the numbers

•MGTX is the larger company ($989M vs $936M market cap).
•MGTX is profitable (19.87% net margin) while KURA runs a net loss (-384.30%).

Metrics side by side

Valuation

Metric	KURA	MGTX
P/E ratio	N/A	15.04
Forward P/E	N/A	35.60
P/S ratio	12.12	2.49
P/B ratio	19.32	4.59
EV / EBITDA	N/A	4.88

Profitability

Metric	KURA	MGTX
Gross margin	94.73%	97.19%
Operating margin	-449.94%	-130.20%
Net margin	-384.30%	19.87%
ROE	-612.78%	36.64%
ROIC	-67.13%	52.81%

Growth (annualized)

Metric	KURA	MGTX
Revenue CAGR (5Y)	N/A	84.52%
Total return CAGR (5Y)	-10.73%	-3.10%

Some values include inputs from SEC filing.

Frequently asked

Is KURA or MGTX more profitable?: MGTX runs the higher net margin — KURA at -384.30% versus MGTX at 19.87%.
How have KURA and MGTX total returns compared?: Over the past 5 years, KURA delivered -10.73% and MGTX delivered -3.10% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KURA analysis Full MGTX analysis Interactive comparison tool

Dig into the metrics

MeiraGTx P/E ratio Kura Oncology ROE MeiraGTx ROE Kura Oncology operating margin MeiraGTx operating margin Kura Oncology revenue growth MeiraGTx revenue growth Kura Oncology free cash flow MeiraGTx free cash flow

Kura Oncology & MeiraGTx appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.